StreetInsider.com News Articles

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: Vos Alexander

Tue, 02 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260602/26592027.html

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: Vos Alexander

Tue, 02 Jun 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260602/26592027.html

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: ROBERTSON BRETT

Tue, 02 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260602/26591997.html

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: ROBERTSON BRETT

Tue, 02 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260602/26591997.html

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: DEMSKI MARTHA J

Tue, 02 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260602/26591931.html

Form 4 Alpha Teknova, Inc. For: Jun 01 Filed by: DEMSKI MARTHA J

Tue, 02 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260602/26591931.html

Form 8-K Alpha Teknova, Inc. For: May 27

Mon, 01 Jun 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260601/26585104.html

Form 8-K Alpha Teknova, Inc. For: May 27

Mon, 01 Jun 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260601/26585104.html

BTIG Reiterates Neutral Rating on Alpha Teknova Inc. (TKNO)

Thu, 14 May 2026 06:06:46 -0400

BTIG analyst Mark Massaro reiterated a Neutral rating and {REMOVEPT} price target on Alpha Teknova Inc. (NASDAQ: TKNO).

The analyst commented: "We update our TKNO model following the company's Q1 results, where TKNO delivered a modest Q1 beat. The key highlight from the Q1 call was the company's strong +85% Y/Y revenue growth in its clinical solutions business; however, unfortunately this segment is just ~20% of its overall revenue. While still small and lumpy, management is seeing an increase in its clinical solutions business in customer count, breadth, and higher revenue per customer across end markets in both diagnostic tests and

Form 10-Q Alpha Teknova, Inc. For: Mar 31

Thu, 07 May 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260507/26453540.html

Form 10-Q Alpha Teknova, Inc. For: Mar 31

Thu, 07 May 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260507/26453540.html

Alpha Teknova, Inc. (TKNO) Tops Q1 EPS by 1c

Thu, 07 May 2026 10:08:41 -0400

Alpha Teknova, Inc. (NASDAQ: TKNO) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $11.07 million versus the consensus estimate of $10.19 million.

For earnings history and earnings-related data on Alpha Teknova, Inc. (TKNO) click here.

Form 8-K Alpha Teknova, Inc. For: May 04

Wed, 06 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260506/26443861.html

Form 8-K Alpha Teknova, Inc. For: May 04

Wed, 06 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260506/26443861.html

Teknova Reports First Quarter 2026 Financial Results

Wed, 06 May 2026 16:01:00 -0400

First quarter 2026 total revenue was $11.1 million, up 13% over the same quarter prior year
Company reaffirms 2026 revenue guidance of $42-44 million

HOLLISTER, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the first quarter ended March 31, 2026.

“We had a great start to 2026,” said Stephen Gunstream, President and Chief Executive Officer at Teknova. “The substantial investments we’ve made since 2021,

Teknova Reports First Quarter 2026 Financial Results

Wed, 06 May 2026 16:01:00 -0400

First quarter 2026 total revenue was $11.1 million, up 13% over the same quarter prior year
Company reaffirms 2026 revenue guidance of $42-44 million

“We had a great start to 2026,” said Stephen Gunstream, President and Chief Executive Officer at Teknova. “The substantial investments we’ve made since 2021,

Teknova to Report First Quarter 2026 Financial Results on May 6, 2026

Wed, 22 Apr 2026 16:01:00 -0400

HOLLISTER, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, following the close of market.

Teknova will host a webcast and conference call on Wednesday, May 6, 2026, beginning at 6:00 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor